Diagnostic significance of paradoxical left ventricular hypertrophy in detecting cardiac amyloidosis

被引:2
|
作者
Ota, Shingo [1 ,3 ]
Izumiya, Yasuhiro [2 ]
Kitada, Ryoko [2 ]
Nishi, Takahiro [1 ]
Taruya, Akira [1 ]
Wada, Teruaki [1 ]
Takahata, Masahiro [1 ]
Ozaki, Yuichi [1 ]
Kashiwagi, Manabu [1 ]
Shiono, Yasutsugu [1 ]
Kuroi, Akio [1 ]
Takemoto, Kazushi [1 ]
Tanimoto, Takashi [1 ]
Kitabata, Hironori [1 ]
Fukuda, Daiju [2 ]
Tanaka, Atsushi [1 ]
机构
[1] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan
[2] Osaka Metropolitan Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan
[3] Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan
来源
IJC HEART & VASCULATURE | 2023年 / 49卷
关键词
Electrocardiography; Left ventricular hypertrophy; Cardiac amyloidosis; Cardiovascular magnetic resonance imaging; TRANSTHYRETIN; ECHOCARDIOGRAPHY; RECOMMENDATIONS; PREDICTORS; STENOSIS; SOCIETY; VOLTAGE;
D O I
10.1016/j.ijcha.2023.101279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiac amyloidosis (CA) progresses rapidly with a poor prognosis. Therefore, methods for early diagnosis that are easily accessible in any hospital, are required. We hypothesized that based on the pathology of CA, morphological left ventricular hypertrophy (LVH) without electrical augmentation, namely paradoxical LVH, could be used to diagnose CA. This study aimed to investigate whether paradoxical LVH has diagnostic significance in identifying CA in patients with LVH. Methods: Patients who presented with left ventricular (LV) wall thickness >= 12 mm on cardiac magnetic res-nance (CMR) were enrolled from a multicentre CMR registry. Paradoxical LVH was defined as a LV wall thickness >= 12 mm on CMR, SV1 + RV5 < 3.5 mV, and a lack of secondary ST-T abnormalities. The diagnostic significance of paradoxical LVH in identifying CA was assessed. Results: Of the 110 patients enrolled, 30 (27 %) were diagnosed with CA and 80 (73 %) with a non-CA aetiology. The CA group demonstrated paradoxical LVH more frequently than the non-CA group (80 % vs. 16 %, P < 0.001). It was an independent predictor for detecting CA in patients with LVH (odds ratio: 33.44, 95 % confidence interval: 8.325-134.3, P < 0.001). The sensitivity, specificity, positive predict value, negative predict value and accuracy of paradoxical LVH for CA detection were 80 %, 84 %, 65 %, 92 % and 83 %, respectively. Conclusions: Paradoxical LVH can be used for identifying CA in patients with LVH. Our findings could contribute to the early diagnosis of CA, even in non-specialized hospitals.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Determinants of left atrial reservoir strain and diagnostic potential for cardiac amyloidosis in pathological left ventricular hypertrophy
    Inoue, Katsuji
    Nakao, Yasuhisa
    Saito, Makoto
    Kinoshita, Masaki
    Higashi, Haruhiko
    Yamaguchi, Osamu
    CARDIOVASCULAR ULTRASOUND, 2025, 23 (01)
  • [2] Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis
    Cariou, Eve
    Smires, Youssef Bennani
    Victor, Gerard
    Robin, Guillaume
    Ribes, David
    Pascal, Pierre
    Petermann, Antoine
    Fournier, Pauline
    Faguer, Stanislas
    Roncalli, Jerome
    Rousseau, Herve
    Chauveau, Dominique
    Carrie, Didier
    Berry, Isabelle
    Galinier, Michel
    Lairez, Olivier
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 (02): : 101 - 109
  • [3] Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
    Polo, Jorge Melero
    Barrenechea, Ana Roteta Unceta
    Marti, Pablo Revilla
    Gutierrez, Anyuli Gracia
    Juana, Esperanza Bueno
    Ayala, Saida Atienza
    Arregui, Miguel Angel Aibar
    CARDIOLOGY JOURNAL, 2023, 30 (02) : 266 - 275
  • [4] Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
    Melero Polo, Jorge
    Roteta Unceta-Barrenechea, Ana
    Revilla Marti, Pablo
    Raquel Perez-Palacios
    Gracia Gutierrez, Anyuli
    Bueno Juana, Esperanza
    Andres Gracia, Alejandro
    Atienza Ayala, Saida
    Aibar Arregui, Miguel Angel
    CARDIOLOGY JOURNAL, 2021,
  • [5] Cardiac Amyloidosis: A Great Pretender of Left Ventricular Hypertrophy with Systemic Manifestation
    Tampi, G. G.
    Farissa, I. P.
    Nugroho, M. A.
    Dewi, R. A. C. K.
    Pangarsa, E. A.
    Hellmi, R. Y.
    Rahardjo, S. B.
    Puspasari, D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
  • [6] Paradoxical Left Ventricular Hypertrophy by Echocardiogram and Low Voltage ECG: A Key Clue in the Diagnostic Workup of Two Distinct Presentations of Cardiac AL Amyloidosis
    Tolu-Akinnawo, Oluwaremilekun
    Oyeleye, Kikelola
    Thayer, Timothy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [7] Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy
    Henein, M. Y.
    Pilebro, B.
    Lindqvist, Per
    HEART AND VESSELS, 2022, 37 (09) : 1562 - 1569
  • [8] Diagnostic utility of the electrocardiographic left ventricular hypertrophy criteria in specific populations
    De la Garza Salazar, Fernando
    Rodriguez Diaz, Elias Abraham
    Gonzalez Cantu, Arnulfo
    Azpiri Lopez, Jose Ramon
    Kuri Ayache, Mauricio
    Romero Ibarguengoitia, Maria Elena
    ACTA CARDIOLOGICA, 2021, 76 (03) : 272 - 279
  • [9] Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy
    Lavall, Daniel
    Vosshage, Nicola H.
    Gessner, Romy
    Stoebe, Stephan
    Ebel, Sebastian
    Denecke, Timm
    Hagendorff, Andreas
    Laufs, Ulrich
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (03) : 334 - 342
  • [10] Cardiac amyloidosis screening using a relative apical sparing pattern in patients with left ventricular hypertrophy
    Nakao, Yasuhisa
    Saito, Makoto
    Inoue, Katsuji
    Higaki, Rieko
    Yokomoto, Yuki
    Ogimoto, Akiyoshi
    Suzuki, Moeko
    Kawakami, Hideo
    Hiasa, Go
    Okayama, Hideki
    Ikeda, Shuntaro
    Yamaguchi, Osamu
    CARDIOVASCULAR ULTRASOUND, 2021, 19 (01)